AzTrials
AzTrials

BurnoutNCT07298018

A Pilot Study of RISE for Nurse Managers Retreat

A study testing Intervention Group in people with Burnout and Secondary Traumatic Stress, run by AdventHealth at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the feasibility and acceptability of the RISE for Nurse Managers retreat and its impact on occupational and psychological well-being indicators Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Intervention Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
29 Jan 2026to 16 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • an employed AdventHealth Nurse Manager
  • a "moderate" or "high" score in burnout equal to ≥17 in the Emotional Exhaustion Domain and/or ≥7 in the Depersonalization Domain on the MBI

Who cannot join

  • a direct care RN, Nurse Director, Educator, and Executive
  • a "low" score in burnout equal to <17 in the Emotional Exhaustion domain and/or <7 in the Depersonalization domain on the MBI

Trial locations and contacts

1 site in 1 country.

United States1 site
  • AdventHealth

    Orlando, Florida, 32804

Other trials in United States

About this study

The purpose of this study is to determine the feasibility and acceptability of the RISE for Nurse Managers retreat and its impact on occupational and psychological well-being indicators

Read the detailed description

The RISE program is an empirically supported wellbeing intervention for nurses and nurse leaders delivered over 8 or 9 weeks in 90-minute weekly sessions facilitated by a licensed mental health professional. The program themes are Resilience, Insight, Self-Compassion, and Empowerment. This study will be to examine the feasibility and acceptability of delivering the program in a retreat style format over 2.5 days.

Being tested
Intervention Group
Medical subject headings
Burnout, Psychological, Compassion Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention GroupBehavioural

    Psychoeducational group program designed to impact occupational and psychological indicators including resilience, insight, self-compassion, empowerment, burnout and secondary trauma

Study groups in NCT07298018
Study groupRoleWhat they receive
Participant groupExperimentalIntervention group will attend the RISE Retreat program, which is a 2.5-day retreat-style psychoeducational group program facilitated by licensed mental health professionals (LMHPs)
Receives: Behavioral: Intervention Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maslach Burnout Inventory - Human Services Survey

    22-item questionnaire with the following response categories: 0=never, 1=a few times a year or less, 2=once a month or less, 3=a few times a month, 4=once a week, 5=a few times a week, 6=every day. MBI includes 3 dimensions of Burnout: Emotional Exhaustion, Depersonalization, and Personal Accomplishment. There are 9 items included in Emotional Exhaustion and scores can range from 0-54. There are 5 items included in Depersonalization and scores can range from 0-30. There are 8 items included in Personal Accomplishment and scores can range from 0-48. Higher scores on Emotional Exhaustion and Depersonalization and lower scores on Personal Accomplishment are indicative of Burnout

    Measured: Baseline, 1-month follow-up, 3-month follow-up, 6-month follow-up

Secondary outcomes (11)
  1. Professional Quality of Life Scale

    30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often. PROQOL includes 3 dimensions: Compassion Satisfaction, Burnout, and Secondary Traumatic Stress. Each subscale includes 10 items and scores can range from 10-50. For Burnout and Secondary Traumatic Stress, lower scores are better. Sums of 10-22 = low level, 23-41 = average level, and 42-50=high level of Burnout and Secondary Traumatic Stress. For Compassion Satisfaction, higher scores are better. Sum of 10-22=low level, 23-41=average level, and 42-50=high level of Compassion Satisfaction.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  2. Brief Resilience Scale

    6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree. Sum of items can range from 6-30, which is then divided by 6 to get an average score. Higher score is better, with 1-2.99 = low resilience, 3-4.3 = normal resilience, and 4.31-5.0 = high resilience.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  3. Self-Reflection and Insight Scale

    20-item questionnaire with the following response categories: 1=strongly disagree, 2, 3, 4, 5, 6=strongly agree. Six items are included in Self-Reflection and scores can range from 6-42, with higher scores indicating a greater self-reflection. Six items are included in Insight, and scores can also range from 6-42 with higher scores indicating more Insight.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  4. Self-Compassion Scale Short Form

    12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always. Scores are added and then averaged. While the average score is to be used comparatively, score 1.0-2.49 is considered low, 2.5-3.5 is considered moderate, and 3.51-5.0 is considered high.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  5. General Self-Efficacy Scale

    10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true. Item scores are added together and then averaged with higher scores indicating more self-efficacy.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  6. Perceived Stress Scale

    10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often. The total score ranges from 0 to 40 with higher scores indicating greater perceived stress.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  7. Generalized Anxiety Disorder - 2 item scale

    2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is 0 to 6 and a score of 3 or higher suggests possible anxiety.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  8. Patient Health Questionnaire - 2 item

    2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is from 0 to 6, and a score of 3 or more indicates possible depressed mood.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  9. Post-Traumatic Growth Inventory

    21-item scale scored using six-point responses: zero ("I did not experience this change as a result of my crisis") to five ("I experienced this change to a very great degree as a result of my crisis"). Total score range is 0 to 105, which higher scores indicating more post traumatic growth.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  10. Psychological Empowerment Instrument

    12-item measure that assesses empowerment in the workplace using a 7-point Likert response scale. Four aspects are measured: meaning, competence, self-determination, and impact. Total score range from 12 to 84, with higher scores indicating greater psychological empowerment.

    Measured: Baseline, 1- and 3-and 6-month follow-up

  11. Employment Status

    Human Resources Data

    Measured: 12-month post-program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2025
  2. Study start29 Jan 2026
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion16 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Single group assignment
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07298018
Sponsor's protocol ID
2365808
Status last verified
Oct 2026
First submitted
11 Dec 2025
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bailey AK, Sawyer AT, Robinson PS. A Psychoeducational Group Intervention for Nurses: Rationale, Theoretical Framework, and Development. J Am Psychiatr Nurses Assoc. 2023 May-Jun;29(3):232-240. doi: 10.1177/10783903211001116. Epub 2021 Jun 22.

    PubMed 34154451
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PubMed 6668417
  • Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004.

    PubMed 17339617
  • Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.

    PubMed 14583691
  • Litz BT, Plouffe RA, Nazarov A, Murphy D, Phelps A, Coady A, Houle SA, Dell L, Frankfurt S, Zerach G, Levi-Belz Y; Moral Injury Outcome Scale Consortium. Defining and Assessing the Syndrome of Moral Injury: Initial Findings of the Moral Injury Outcome Scale Consortium. Front Psychiatry. 2022 Jul 5;13:923928. doi: 10.3389/fpsyt.2022.923928. eCollection 2022.

    PubMed 35873252
  • Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory manual, 3rd ed. Palo Alto, CA: Consulting Psychologists Press, 1996.

  • Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8.

    PubMed 21584907
  • Sawyer AT, Bailey AK, Green JF, Sun J, Robinson PS. Resilience, Insight, Self-Compassion, and Empowerment (RISE): A Randomized Controlled Trial of a Psychoeducational Group Program for Nurses. J Am Psychiatr Nurses Assoc. 2023 Jul-Aug;29(4):314-327. doi: 10.1177/10783903211033338. Epub 2021 Jul 23.

    PubMed 34293934
  • Sawyer AT, Tao H, Bailey AK. The Impact of a Psychoeducational Group Program on the Mental Well-Being of Unit-Based Nurse Leaders: A Randomized Controlled Trial. Int J Environ Res Public Health. 2023 Jun 2;20(11):6035. doi: 10.3390/ijerph20116035.

    PubMed 37297639
  • Schwarzer, R., & Jerusalem, M. (1995). Generalized Self-Efficacy Scale. J. Weinman, S. Wright, & M. Johnston, Measures in health psychology: A user's portfolio. Causal and control beliefs, 35, 37.

  • Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.

    PubMed 18696313
  • Spreitzer GM. Psychological empowerment in the workplace: Dimensions, measurement, and validation. Academy of Management Journal. 1995; 38(5):1442-1465.

  • Stamm, B. H. (2010). Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL). http://www.proqol.org.

  • Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996 Jul;9(3):455-71. doi: 10.1007/BF02103658.

    PubMed 8827649

Questions about this trial

What is this clinical trial studying?

A study testing Intervention Group in people with Burnout and Secondary Traumatic Stress, run by AdventHealth at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maslach Burnout Inventory - Human Services Survey (time frame: Baseline, 1-month follow-up, 3-month follow-up, 6-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07298018, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in